Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 3.00
Ask: 4.00
Change: -0.40 (-10.26%)
Spread: 1.00 (33.333%)
Open: 3.90
High: 0.00
Low: 0.00
Prev. Close: 3.90
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

1 Feb 2010 14:01

RNS Number : 4634G
Proteome Sciences PLC
01 February 2010
 



 

 

TR-1: Notifications of Major Interests in Shares

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

Proteome Sciences plc

 

2. Reason for notification (yes/no)

 

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An event changing the breakdown of voting rights

 

Other (please specify):______________

 

3. Full name of person(s) subject to notification obligation:

 

Cubana Investments Limited

 

4. Full name of shareholder(s) (if different from 3):

 

 

 

5. Date of transaction (and date on which the threshold is crossed or reached if different):

 

29 January 2010

 

6. Date on which issuer notified:

 

1 February 2010

 

7. Threshold(s) that is/are crossed or reached:

 

>12%

 

 

 

 

 

8: Notified Details

A: Voting rights attached to shares

 

Class/type of shares

If possible use ISIN code

 

GB0003104196

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

 

15,187,465

Number of voting rights

15,187,465

Number of shares

 

16,193,355

Number of voting rights

Percentage of voting rights

 

Direct

16,193,355

 

Indirect

16,193,355

 

Direct

12.19%

 

Indirect

12.19%

 

 

 

B: Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

 

 

 

 

Total (A+B)

 

Number of voting rights

Percentage of voting rights

16,187,465

12.19%

 

 

 

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

 

Proxy Voting:

 

10. Name of proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14 Contact name:

 

James Malthouse

15. Contact telephone name:

 

+44 1932 865065

 

For notes on how to complete form TR-1 please see the FSA website.

Note: Annex should only be submitted to the FSA not the issuer

 

Annex: Notification of major interests in shares

 

 

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Cubana Investments Limited

Contact address

(registered office for legal entities)

 

PO Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands

Other useful information

(at least legal representative for legal persons)

 

 

B: Identity of the notifier, if applicable

Full name

 

Andy Ng

Contact address

 

59 Club Street, 2nd Floor, Singapore 069 434

Phone number & email

 

+65 6538 1998 : andy.ng@gfia.com.sg

Other useful information

 

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

Compliance Officer

 

C: Additional information

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGUUUPUPUGCG
Date   Source Headline
24th Feb 20147:00 amRNSPlacing
7th Feb 20147:00 amRNSTrading Update
3rd Feb 20144:44 pmRNSHolding(s) in Company
27th Dec 20134:35 pmRNSPrice Monitoring Extension
4th Dec 20137:00 amRNSTrading Update
20th Nov 20137:00 amRNSPatient Stratification Biomarkers for Liver Cancer
6th Nov 20132:51 pmRNSHolding(s) in Company
1st Oct 201310:34 amRNSBlocklisting Interim Review
30th Sep 20137:00 amRNSHalf Yearly Report
18th Sep 20132:00 pmRNSKey Assay Development at HUPO
2nd Sep 201312:12 pmRNSHolding(s) in Company
6th Aug 201312:36 pmRNSIssue of Equity
18th Jul 20137:00 amRNSNew Data Shows CK1d Blocks Tau in AD Model
28th Jun 20131:00 pmRNSAGM Statement
28th Jun 20137:00 amRNSPatent Statement
26th Jun 20139:27 amRNSHolding(s) in Company
12th Jun 20137:00 amRNSMajor technology contract
5th Jun 20134:08 pmRNSAnnual Financial Report
30th May 20137:01 amRNSPreliminary Results
19th Apr 20137:00 amRNSTrading Update
2nd Apr 20137:00 amRNSBlock admission return
18th Mar 20137:00 amRNSDevelopments in Alzheimer's Disease
22nd Jan 20137:00 amRNSTrading Statement
31st Dec 20127:00 amRNSCK1D Update
3rd Dec 201211:06 amRNSHolding(s) in Company
28th Sep 20127:00 amRNSHalf Yearly Report
18th Sep 20124:04 pmRNSBlock Admission Return
18th Sep 20124:01 pmRNSBlock Admission Return
18th Sep 20127:00 amRNSFurther re. University of Geneva Study
20th Aug 20127:00 amRNSRe Agreement
29th Jun 201212:10 pmRNSAGM Statement
7th Jun 20123:10 pmRNSAnnual Financial Report
29th May 20127:00 amRNSFinal Results
30th Apr 20127:00 amRNSTotal Voting Rights
5th Apr 20127:00 amRNSStroke biomarker license to Randox
29th Mar 20125:11 pmRNSBlock Admission Return
28th Mar 20127:00 amRNSCompletion of Alzheimer's Plasma Biomarker Study
19th Mar 201210:00 amRNSEuroHYP EU Grant Award for Stroke
8th Mar 20128:55 amRNSHolding(s) in Company
5th Mar 20127:00 amRNSChange of Adviser
24th Feb 20124:24 pmRNSDirector/PDMR Shareholding
31st Jan 20127:00 amRNSTotal Voting Rights
18th Jan 20127:00 amRNSAdditional Listing
22nd Dec 20117:00 amRNSPromising hits against Alzheimer's Target
24th Nov 20117:00 amRNSNovel In Vitro Assays Developed
8th Nov 20113:39 pmRNSDirector Holdings
7th Oct 20117:00 amRNSBlock Admission Return
30th Sep 20117:00 amRNSInterim Results 2011
11th Aug 20114:35 pmRNSPrice Monitoring Extension
11th Aug 20111:33 pmRNSNotification of Major interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.